ROMAGNOLI, Dante
 Distribuzione geografica
Continente #
NA - Nord America 4.082
EU - Europa 1.810
AS - Asia 1.524
SA - Sud America 201
AF - Africa 35
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.686
Nazione #
US - Stati Uniti d'America 4.049
SG - Singapore 522
CN - Cina 478
GB - Regno Unito 415
IT - Italia 280
PL - Polonia 239
HK - Hong Kong 194
DE - Germania 190
FI - Finlandia 178
SE - Svezia 166
BR - Brasile 163
VN - Vietnam 106
RU - Federazione Russa 97
UA - Ucraina 62
FR - Francia 50
TR - Turchia 47
ID - Indonesia 40
IN - India 29
BG - Bulgaria 28
AU - Australia 27
LT - Lituania 26
KR - Corea 25
AR - Argentina 24
JP - Giappone 21
CA - Canada 20
NL - Olanda 18
BD - Bangladesh 12
EG - Egitto 10
AT - Austria 9
BE - Belgio 9
ES - Italia 9
MX - Messico 9
ZA - Sudafrica 9
IE - Irlanda 8
CZ - Repubblica Ceca 6
IQ - Iraq 6
MY - Malesia 6
EU - Europa 5
PK - Pakistan 5
BH - Bahrain 4
CH - Svizzera 4
EC - Ecuador 4
SA - Arabia Saudita 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DK - Danimarca 3
ET - Etiopia 3
IR - Iran 3
KE - Kenya 3
MA - Marocco 3
UZ - Uzbekistan 3
BO - Bolivia 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TJ - Tagikistan 2
UY - Uruguay 2
AZ - Azerbaigian 1
BZ - Belize 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
MZ - Mozambico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.686
Città #
Fairfield 505
Ashburn 409
Santa Clara 381
Singapore 364
Woodbridge 295
Chandler 253
Seattle 246
Southend 246
Houston 242
Warsaw 238
Hong Kong 187
Wilmington 187
Helsinki 166
Cambridge 153
Nyköping 125
Dearborn 123
Hefei 108
Ann Arbor 99
London 87
Modena 84
Jacksonville 77
New York 72
Beijing 70
San Jose 59
Los Angeles 49
Chicago 41
Shanghai 38
The Dalles 37
San Diego 34
Izmir 32
Council Bluffs 31
Ho Chi Minh City 31
Jakarta 28
Sofia 28
Hanoi 26
Moscow 26
Princeton 26
Eugene 25
Seoul 25
Munich 23
Melbourne 19
Guangzhou 18
Salt Lake City 18
Buffalo 15
Milan 15
São Paulo 15
Denver 14
Redwood City 14
Dallas 12
Redondo Beach 12
Frankfurt am Main 11
Rome 11
Dong Ket 10
Fremont 10
Phoenix 10
Stockholm 10
Bologna 9
Bremen 9
Brussels 9
Lauterbourg 9
San Mateo 9
Tokyo 9
Amsterdam 8
Dublin 8
Padova 8
Boardman 7
Boston 7
Carpi 7
Nanjing 7
Semarang 7
Atlanta 6
Brno 6
Florence 6
Haiphong 6
Kent 6
Montreal 6
Portsmouth 6
Rio de Janeiro 6
Shibīn al Kawm 6
Chennai 5
Columbus 5
Da Nang 5
Gifu 5
Grafing 5
Johannesburg 5
Nuremberg 5
Paris 5
Poplar 5
Sterling 5
Tampa 5
Toronto 5
Vienna 5
Ankara 4
Brooklyn 4
Charleston 4
Düsseldorf 4
Hangzhou 4
Kunming 4
L'Hospitalet de Llobregat 4
Livorno 4
Totale 5.754
Nome #
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 441
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 410
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 345
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 316
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 305
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 296
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 295
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 295
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 286
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 285
Nonalcoholic fatty liver disease and aging: epidemiology to management 272
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 263
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 258
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 245
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 233
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in Italy 231
Alcohol and Steatosis: The Japanese Paradox 229
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 226
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy 226
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 205
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 200
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 199
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 174
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 174
Gender differences in chronic alcoholic and viral liver diseases 173
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 168
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 166
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 161
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 151
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 140
Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target 137
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy 129
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 124
Totale 7.758
Categoria #
all - tutte 31.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021506 0 0 0 0 0 0 76 130 54 96 96 54
2021/2022523 46 51 19 20 14 37 25 28 68 46 119 50
2022/2023691 68 90 61 77 67 77 15 74 75 9 35 43
2023/2024465 23 33 57 33 71 47 19 36 19 7 52 68
2024/20251.486 30 13 39 105 303 215 108 98 160 66 163 186
2025/20261.870 206 131 210 285 404 501 133 0 0 0 0 0
Totale 7.758